Heptapeptide · Nootropic / neurotrophic research

Semax 10mg

Semax (ACTH(4-10) analogue) · 10mg vial

Semax is a synthetic peptide based on a fragment of adrenocorticotropic hormone (ACTH 4-10), with the hormonal activity engineered out and a Pro-Gly-Pro tail added for stability.

Pricing · per unit

Mix & match any vials — 2–4 −10%, 5+ −15%
Retail1 unitR425
2–4−10%R383
5+−15%R361

In transit · ETA 24 Nov

How it works

Research associates Semax with increased brain-derived neurotrophic factor (BDNF) expression and modulation of dopaminergic and serotonergic signalling.

Research context

Studied mainly in Russian clinical and preclinical work for cognitive and neuroprotective effects; no major regulator has approved it.

Vial contents & handling

  • 10mg Semax
  • Single lyophilised vial

Quality & sourcing. Sourced from established manufacturers who test using HPLC analysis. COA available on request — ask us on WhatsApp ↗

Storage: keep unopened lyophilised vials in a cool, dark place. Once reconstituted, store in the fridge at 2–8°C and use within 2 months.

Research reference dosage

10mg vial · 3ml water · 3.33mg/ml
LevelAmountU100 unitsFrequency
Beginner200mcg6 units1× daily · morning · subq or intranasal
Intermediate300mcg9 units1–2× daily · morning + early afternoon
Advanced500mcg15 units1–2× daily · morning + early afternoon

Fixed 3ml · U100 device (1 unit = 0.01ml). Published intranasal studies used 400–800mcg per day split into 2–3 administrations. Research reference only.

Dosing status: No approved dosing. Intranasal research commonly cites 400–800mcg per day; injectable reference levels mirror the lower range.

References

Guides

Research use only · Not for human or veterinary consumption · Not for self-administration